SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001645627-18-000038
Filing Date
2018-07-20
Accepted
2018-07-20 16:12:07
Documents
1
Period of Report
2018-07-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 26556
  Complete submission text file 0001645627-18-000038.txt   28161
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Issuer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6320 CANOGA AVENUE WOODLAND HILLS CA 91367
Business Address
Mann Michael Scott (Reporting) CIK: 0001645627 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55453 | Film No.: 18962604